Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara Wegermann

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of the American Heart Association|July 8, 2023
Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver DiseaseKara Wegermann, Marat Fudim, Ricardo Henao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2020
Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver DiseaseMatthew R Kappus, Kara Wegermann, Erol Bozdogan, et al.
European Journal of Heart Failure|May 19, 2025
Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver diseaseKara Wegermann, Fouad Chouairi, Georgia Sofia Karachaliou, et al.
Metabolomics : Official Journal of the Metabolomic Society|July 2, 2025
Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infectionTzu-Hao Lee, Kara Wegermann, Rachel Safeek, et al.
Hepatology Communications|April 16, 2021
Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLDKara Wegermann, Melanie E Garrett, Jiayin Zheng, et al.
ESC Heart Failure|February 15, 2021
Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCATAnthony E Peters, Ambarish Pandey, Colby Ayers, et al.
Journal of the American College of Cardiology|November 12, 2025
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and TreatmentMuhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, et al.
Gastro Hep Advances|April 21, 2025
Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum DiseaseBridget M Geyer, Feier Chang, Peng Wu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 18, 2021
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and OutcomesMariya L Samoylova, Kara Wegermann, Brian I Shaw, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 14, 2025
Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virusTzu-Hao Lee, Kara Wegermann, Ken Sutha, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of the American Heart Association|July 8, 2023
Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver DiseaseKara Wegermann, Marat Fudim, Ricardo Henao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2020
Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver DiseaseMatthew R Kappus, Kara Wegermann, Erol Bozdogan, et al.
European Journal of Heart Failure|May 19, 2025
Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver diseaseKara Wegermann, Fouad Chouairi, Georgia Sofia Karachaliou, et al.
Metabolomics : Official Journal of the Metabolomic Society|July 2, 2025
Bioactive lipid profiles as non-invasive biomarkers of advanced fibrosis in people with HIV/HCV co-infectionTzu-Hao Lee, Kara Wegermann, Rachel Safeek, et al.
Hepatology Communications|April 16, 2021
Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLDKara Wegermann, Melanie E Garrett, Jiayin Zheng, et al.
ESC Heart Failure|February 15, 2021
Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCATAnthony E Peters, Ambarish Pandey, Colby Ayers, et al.
Journal of the American College of Cardiology|November 12, 2025
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and TreatmentMuhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, et al.
Gastro Hep Advances|April 21, 2025
Clinical Phenotypes May be Able to Identify Populations With Nonalcoholic Fatty Liver-Spectrum DiseaseBridget M Geyer, Feier Chang, Peng Wu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 18, 2021
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver-Kidney Utilization and OutcomesMariya L Samoylova, Kara Wegermann, Brian I Shaw, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 14, 2025
Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virusTzu-Hao Lee, Kara Wegermann, Ken Sutha, et al.
Pageof 4